Origin Life Sciences, Inc. (OLSI)
Origin Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
1,875,000
Deal Size
$7.50M

Origin Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Selling, General & Admin
2.886.38
Research & Development
0.050.01
Other Operating Expenses
0.090.09
Operating Expenses
3.026.48
Operating Income
-3.02-6.48
Interest Expense / Income
0.110.05
Other Expense / Income
5.7-0.2
Pretax Income
-8.84-6.33
Net Income
-8.84-6.33
Free Cash Flow
-1.36-0.92
EBITDA
-8.63-6.19
Depreciation & Amortization
0.090.09
EBIT
-8.73-6.28
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).